SOA Wealth Advisors LLC. lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 22.0% during the second quarter, Holdings Channel.com reports. The fund owned 789 shares of the financial services provider’s stock after selling 222 shares during the period. SOA Wealth Advisors LLC.’s holdings in iShares Biotechnology ETF were worth $100,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of IBB. Vigilant Capital Management LLC bought a new position in iShares Biotechnology ETF in the first quarter valued at approximately $26,000. WealthPLAN Partners LLC acquired a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $27,000. Thompson Investment Management Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter valued at $38,000. Red Lighthouse Investment Management LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $39,000. Finally, Lakewood Asset Management LLC acquired a new position in iShares Biotechnology ETF during the fourth quarter worth $39,000. Institutional investors own 69.61% of the company’s stock.
iShares Biotechnology ETF Trading Down 0.8 %
Shares of IBB stock opened at $126.61 on Friday. The company has a fifty day moving average price of $128.08 and a two-hundred day moving average price of $129.36. iShares Biotechnology ETF has a one year low of $113.37 and a one year high of $138.74.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
- Five stocks we like better than iShares Biotechnology ETF
- Space Investment: How to Invest in Space Exploration
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- What is the price-to-earnings growth (PEG) ratio?
- MarketBeat Week in Review – 9/11 – 9/15
- How to Invest in Renewable Energy
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.